Abstract:The MRE11, RAD50, and NBN genes encode for the nuclear MRN protein complex, which senses the DNA double strand breaks and initiates the DNA repair. The MRN complex also participates in the activation of ATM kinase, which coordinates DNA repair with the p53-dependent cell cycle checkpoint arrest. Carriers of homozygous germline pathogenic variants in the MRN complex genes or compound heterozygotes develop phenotypically distinct rare autosomal recessive syndromes characterized by chromosomal instability and neu… Show more
“…This study confirmed the well-known fact that mutations in Mre11 are associated with the reduction or loss of other proteins of the MRN complex, which makes the specific role of Mre11 in cancer predisposition even more elusive [ 75 ]. However, the occurrence of germline Mre11 alterations in a minority of breast cancer patients observed in these studies has not been confirmed in ample case population studies [ 70 ]. It has also been suggested that mutations in Mre11 are associated with increased susceptibility to colorectal cancer.…”
Section: Review and Hypothesismentioning
confidence: 99%
“…Similar to AT, cells derived from patients with NBS exhibit accelerated shortening of telomeres, loss of intra-S and G2/M checkpoint control, and genomic instability [ 69 ]. Another study including 241 cases reported a median age of cancer onset of 9.1 years with a probability of 20-year survival of 44.6% [ 70 ], whereas a murine model in which exons 4 and 5 were replaced by neo did not show increased tumor incidence [ 71 ]. Dumon-Jones et al generated heterozygous knockout (Nbn +/− ) mice that developed a wide array of tumors in addition to lymphomas and gamma-radiation-enhanced tumor development [ 72 ].…”
Contrary to what was once thought, direct cancer originating from normal stem cells seems to be extremely rare. This is consistent with a preneoplastic period of telomere length reduction/damage in committed cells that becomes stabilized in transformation. Multiple observations suggest that telomere damage is an obligatory step preceding its stabilization. During tissue turnover, the telomeres of cells undergoing differentiation can be damaged as a consequence of defective DNA repair caused by endogenous or exogenous agents. This may result in the emergence of new mechanism of telomere maintenance which is the final outcome of DNA damage and the initial signal that triggers malignant transformation. Instead, transformation of stem cells is directly induced by primary derangement of telomere maintenance mechanisms. The newly modified telomere complex may promote survival of cancer stem cells, independently of telomere maintenance. An inherent resistance of stem cells to transformation may be linked to specific, robust mechanisms that help maintain telomere integrity.
“…This study confirmed the well-known fact that mutations in Mre11 are associated with the reduction or loss of other proteins of the MRN complex, which makes the specific role of Mre11 in cancer predisposition even more elusive [ 75 ]. However, the occurrence of germline Mre11 alterations in a minority of breast cancer patients observed in these studies has not been confirmed in ample case population studies [ 70 ]. It has also been suggested that mutations in Mre11 are associated with increased susceptibility to colorectal cancer.…”
Section: Review and Hypothesismentioning
confidence: 99%
“…Similar to AT, cells derived from patients with NBS exhibit accelerated shortening of telomeres, loss of intra-S and G2/M checkpoint control, and genomic instability [ 69 ]. Another study including 241 cases reported a median age of cancer onset of 9.1 years with a probability of 20-year survival of 44.6% [ 70 ], whereas a murine model in which exons 4 and 5 were replaced by neo did not show increased tumor incidence [ 71 ]. Dumon-Jones et al generated heterozygous knockout (Nbn +/− ) mice that developed a wide array of tumors in addition to lymphomas and gamma-radiation-enhanced tumor development [ 72 ].…”
Contrary to what was once thought, direct cancer originating from normal stem cells seems to be extremely rare. This is consistent with a preneoplastic period of telomere length reduction/damage in committed cells that becomes stabilized in transformation. Multiple observations suggest that telomere damage is an obligatory step preceding its stabilization. During tissue turnover, the telomeres of cells undergoing differentiation can be damaged as a consequence of defective DNA repair caused by endogenous or exogenous agents. This may result in the emergence of new mechanism of telomere maintenance which is the final outcome of DNA damage and the initial signal that triggers malignant transformation. Instead, transformation of stem cells is directly induced by primary derangement of telomere maintenance mechanisms. The newly modified telomere complex may promote survival of cancer stem cells, independently of telomere maintenance. An inherent resistance of stem cells to transformation may be linked to specific, robust mechanisms that help maintain telomere integrity.
“…Once a DSB occurs, MRN complex recognizes damaged DNA and initiates a signaling cascade to activate cellular response to repair the break [ 38 ]. MRN complex facilitates autophosphorylation of ataxia telangiectasia mutated (ATM) at serine 1981 (S1981) and autoacetylation of ATM at lysine 3106 (K3106) [ 39 , 40 ].…”
Section: Phase Separation In Dna Double-strand Break Responsementioning
DNA double-strand break (DSB) is the most dangerous type of DNA damage, which may lead to cell death or oncogenic mutations. Homologous recombination (HR) and nonhomologous end-joining (NHEJ) are two typical DSB repair mechanisms. Recently, many studies have revealed that liquid–liquid phase separation (LLPS) plays a pivotal role in DSB repair and response. Through LLPS, the crucial biomolecules are quickly recruited to damaged sites with a high concentration to ensure DNA repair is conducted quickly and efficiently, which facilitates DSB repair factors activating downstream proteins or transmitting signals. In addition, the dysregulation of the DSB repair factor’s phase separation has been reported to promote the development of a variety of diseases. This review not only provides a comprehensive overview of the emerging roles of LLPS in the repair of DSB but also sheds light on the regulatory patterns of phase separation in relation to the DNA damage response (DDR).
“…Specifically, Otahalova et al [ 7 ] outline the structural characteristics of the MRE11, RAD50, and NBN proteins and the assembly and functions of the MRN complex from the perspective of clinical interpretation of germline and somatic alterations in the MRE11, RAD50, and NBN genes. They describe the structure of the MRN Complex and its function in double-strand break (DSB) repair and analyze the different germline alterations of the MRN complex genes in autosomal recessive syndromes, as well as the association between heterozygous germline alterations in these genes and cancer predisposition.…”
mentioning
confidence: 99%
“…They describe the structure of the MRN Complex and its function in double-strand break (DSB) repair and analyze the different germline alterations of the MRN complex genes in autosomal recessive syndromes, as well as the association between heterozygous germline alterations in these genes and cancer predisposition. Their review finally explores the role of somatic alterations in the MRN complex genes in different tumors [ 7 ].…”
In the rapidly evolving landscape of molecular genetics and genomics, this Special Issue brings together a collection of insightful review articles that delve into the forefront of scientific exploration [...]
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.